Protecting small and sick newborn care in the COVID-19 pandemic: multi-stakeholder qualitative data from four African countries with NEST360.

COVID-19 Health systems Health systems shocks Neonatal care Small and sick newborn care

Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
16 11 2023
Historique:
received: 23 01 2023
accepted: 10 10 2023
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 17 11 2023
Statut: epublish

Résumé

Health system shocks are increasing. The COVID-19 pandemic resulted in global disruptions to health systems, including maternal and newborn healthcare seeking and provision. Yet evidence on mitigation strategies to protect newborn service delivery is limited. We sought to understand what mitigation strategies were employed to protect small and sick newborn care (SSNC) across 65 facilities Kenya, Malawi, Nigeria and Tanzania, implementing with the NEST360 Alliance, and if any could be maintained post-pandemic. We used qualitative methods (in-depth interviews n=132, focus group discussions n=15) with purposively sampled neonatal health systems actors in Kenya, Malawi, Nigeria and Tanzania. Data were collected from September 2021 - August 2022. Topic guides were co-developed with key stakeholders and used to gain a detailed understanding of approaches to protect SSNC during the COVID-19 pandemic. Questions explored policy development, collaboration and investments, organisation of care, human resources, and technology and device innovations. Interviews were conducted by experienced qualitative researchers and data were collected until saturation was reached. Interviews were digitally recorded and transcribed verbatim. A common coding framework was developed, and data were coded via NVivo and analysed using a thematic framework approach. We identified two pathways via which SSNC was strengthened. The first pathway, COVID-19 specific responses with secondary benefit to SSNC included: rapid policy development and adaptation, new and collaborative funding partnerships, improved oxygen systems, strengthened infection prevention and control practices. The second pathway, health system mitigation strategies during the pandemic, included: enhanced information systems, human resource adaptations, service delivery innovations, e.g., telemedicine, community engagement and more emphasis on planned preventive maintenance of devices. Chronic system weaknesses were also identified that limited the sustainability and institutionalisation of actions to protect SSNC. Innovations to protect SSNC in response to the COVID-19 pandemic should be maintained to support resilience and high-quality routine SSNC delivery. In particular, allocation of resources to sustain high quality and resilient care practices and address remaining gaps for SSNC is critical.

Sections du résumé

BACKGROUND
Health system shocks are increasing. The COVID-19 pandemic resulted in global disruptions to health systems, including maternal and newborn healthcare seeking and provision. Yet evidence on mitigation strategies to protect newborn service delivery is limited. We sought to understand what mitigation strategies were employed to protect small and sick newborn care (SSNC) across 65 facilities Kenya, Malawi, Nigeria and Tanzania, implementing with the NEST360 Alliance, and if any could be maintained post-pandemic.
METHODS
We used qualitative methods (in-depth interviews n=132, focus group discussions n=15) with purposively sampled neonatal health systems actors in Kenya, Malawi, Nigeria and Tanzania. Data were collected from September 2021 - August 2022. Topic guides were co-developed with key stakeholders and used to gain a detailed understanding of approaches to protect SSNC during the COVID-19 pandemic. Questions explored policy development, collaboration and investments, organisation of care, human resources, and technology and device innovations. Interviews were conducted by experienced qualitative researchers and data were collected until saturation was reached. Interviews were digitally recorded and transcribed verbatim. A common coding framework was developed, and data were coded via NVivo and analysed using a thematic framework approach.
FINDINGS
We identified two pathways via which SSNC was strengthened. The first pathway, COVID-19 specific responses with secondary benefit to SSNC included: rapid policy development and adaptation, new and collaborative funding partnerships, improved oxygen systems, strengthened infection prevention and control practices. The second pathway, health system mitigation strategies during the pandemic, included: enhanced information systems, human resource adaptations, service delivery innovations, e.g., telemedicine, community engagement and more emphasis on planned preventive maintenance of devices. Chronic system weaknesses were also identified that limited the sustainability and institutionalisation of actions to protect SSNC.
CONCLUSION
Innovations to protect SSNC in response to the COVID-19 pandemic should be maintained to support resilience and high-quality routine SSNC delivery. In particular, allocation of resources to sustain high quality and resilient care practices and address remaining gaps for SSNC is critical.

Identifiants

pubmed: 37974092
doi: 10.1186/s12887-023-04358-7
pii: 10.1186/s12887-023-04358-7
pmc: PMC10655439
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

572

Informations de copyright

© 2023. The Author(s).

Références

Women Birth. 2022 Jul;35(4):378-386
pubmed: 34531166
BMC Pregnancy Childbirth. 2015;15 Suppl 2:S7
pubmed: 26391335
Qual Health Res. 2022 Apr;32(5):729-743
pubmed: 35094621
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33632772
PLoS One. 2021 Dec 16;16(12):e0260006
pubmed: 34914748
Soc Sci Med. 2003 Apr;56(7):1453-68
pubmed: 12614697
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
BMJ Glob Health. 2022 Feb;7(2):
pubmed: 35173022
Soc Sci Med. 2018 Jul;209:1-13
pubmed: 29777956
BMJ Glob Health. 2022 Feb;7(2):
pubmed: 35144921
Health Policy Plan. 2012 Jul;27 Suppl 3:iii6-28
pubmed: 22692417
Lancet Psychiatry. 2021 Jun;8(6):535-550
pubmed: 33639109
Pan Afr Med J. 2020 Jun 24;35(Suppl 2):89
pubmed: 33623613
EClinicalMedicine. 2021 Mar;33:100733
pubmed: 33748724
Glob Health Res Policy. 2022 Jul 20;7(1):20
pubmed: 35854345
PLoS One. 2021 Dec 10;16(12):e0259835
pubmed: 34890417
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Lancet Glob Health. 2020 Oct;8(10):e1273-e1281
pubmed: 32791117
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33716220
BMC Pregnancy Childbirth. 2015 Feb 18;15:39
pubmed: 25879579
EClinicalMedicine. 2021 Aug 06;39:101056
pubmed: 34401688
Health Policy Plan. 2012 Jul;27 Suppl 3:iii88-103
pubmed: 22692419
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33509839
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33051285
Paediatr Child Health. 2003 Dec;8(10):602-3
pubmed: 20019848
Curr Trop Med Rep. 2021;8(3):183-189
pubmed: 33996382
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
BMJ Glob Health. 2017 Apr 4;2(2):e000205
pubmed: 28589020

Auteurs

Rosie Steege (R)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK. rosie.steege@lshtm.ac.uk.
Liverpool School of Tropical Medicine, Liverpool, UK. rosie.steege@lshtm.ac.uk.

Hannah Mwaniki (H)

Aga Khan University, Nairobi, Kenya.

Ifeanyichukwu Anthony Ogueji (IA)

NEST360/APIN Public Health Initiative, Connal Road, Yaba, Lagos State, Nigeria.

Jitihada Baraka (J)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Sangwani Salimu (S)

Kamuzu University of Health Sciences, Blantyre, Malawi.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Meghan Bruce Kumar (MB)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK.
Kenya Medical Research Institute, Wellcome Trust Research Program, Nairobi, Kenya.

Kondwani Kawaza (K)

Kamuzu University of Health Sciences, Blantyre, Malawi.
Department of Pediatrics, Kamuzu Central Hospital, Lilongwe, Malawi.

Opeyemi Odedere (O)

Rice360 Institute for Global Health Technologies, Houston, Texas, USA.

Donat Shamba (D)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.

Helen Bokea (H)

Rice360 Institute for Global Health Technologies, Houston, Texas, USA.

Msandeni Chiume (M)

Kamuzu University of Health Sciences, Blantyre, Malawi.
Kamuzu Central Hospital, Lilongwe, Malawi.

Steve Adudans (S)

Academy for Novel Channels in Health and Operations Research (ACANOVA Africa), Nairobi, Kenya.

Chinyere Ezeaka (C)

College of Medicine, University of Lagos, Lagos State, Nigeria.

Catherine Paul (C)

Rice360 Institute for Global Health Technologies, Houston, Texas, USA.

Laurent Banyira (L)

Malawi Adventist University, Ntcheu, Malawi.

Gaily Lungu (G)

Kamuzu University of Health Sciences, Blantyre, Malawi.

Nahya Salim (N)

Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ifakara Health Institute, Dar es Salaam, Tanzania.

Evelyn Zimba (E)

Rice360 Institute for Global Health Technologies, Houston, Texas, USA.

Samuel Ngwala (S)

Kamuzu University of Health Sciences, Blantyre, Malawi.

Alice Tarus (A)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK.

Christine Bohne (C)

Department of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Dar es Salaam, Tanzania.
Rice360 Institute for Global Health Technologies, Houston, Texas, USA.

David Gathara (D)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK. David.gathara1@lshtm.ac.uk.
Kenya Medical Research Institute, Wellcome Trust Research Program, Nairobi, Kenya. David.gathara1@lshtm.ac.uk.

Joy E Lawn (JE)

Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK. Joy.lawn@lshtm.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH